Dr. Joseph Kozikowski will present on the use of nanoscale molecular imaging in breast cancer at GE Healthcare imaging global headquarters.
FRAMINGHAM, MA – October 1, 2004 – Clinivation, Inc. announced today that clinivation Founder and CEO Joseph Kozikowski, M.D. will present to research and executive leadership at GE Healthcare Imaging Global Headquarters in Waukesha, WI.
As an authority on the development and commercialization of advanced medical technology, Dr. Kozikowski will share his perspectives in a presentation entitled “Strategic Market Analysis of Established and Emerging Technologies in Breast Cancer Screening, Diagnosis, Staging, and Treatment Monitoring” on October 15, 2004.
The presentation will address Dr. Kozikowski’s translational research in nanoscale molecular imaging and cancer as Chief Medical Officer and Study Medical Director of ART Advanced Research Technologies Inc. (Technoparc Saint-Laurent, CAN).
About GE Healthcare:
GE Healthcare provides transformational medical technologies that will shape a new age of patient care. GE Healthcare’s expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceuticals is dedicated to detecting disease earlier and tailoring treatment for individual patients. GE Healthcare offers a broad range of services to improve productivity in healthcare and enable healthcare providers to better diagnose, treat and manage patients with conditions such as cancer, Alzheimer’s and cardiovascular diseases.
GE Healthcare is a $14 billion unit of General Electric Company (NYSE: GE) that is headquartered in the United Kingdom. Worldwide, GE Healthcare employs more than 42,500 people committed to serving healthcare professionals and their patients in more than 100 countries.
